ES2149691B1 - 2-4-(4-(4,5-dicloro-2-metilimidazol-1-il)butil)-1-piperacinil)-5-fluoropirimidina, su preparacion y su utilizacion terapeutica. - Google Patents

2-4-(4-(4,5-dicloro-2-metilimidazol-1-il)butil)-1-piperacinil)-5-fluoropirimidina, su preparacion y su utilizacion terapeutica.

Info

Publication number
ES2149691B1
ES2149691B1 ES009801201A ES9801201A ES2149691B1 ES 2149691 B1 ES2149691 B1 ES 2149691B1 ES 009801201 A ES009801201 A ES 009801201A ES 9801201 A ES9801201 A ES 9801201A ES 2149691 B1 ES2149691 B1 ES 2149691B1
Authority
ES
Spain
Prior art keywords
methylimidazol
preparation
therapeutic use
fluoropirimidine
piperacinil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009801201A
Other languages
English (en)
Other versions
ES2149691A1 (es
Inventor
Vidal Ramon Merce
Constansa Jordi Frigola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of ES2149691A1 publication Critical patent/ES2149691A1/es
Application granted granted Critical
Publication of ES2149691B1 publication Critical patent/ES2149691B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Abstract

2-{4-[4-(4,5-dicloro-2-metilimidazol-1-il)butil]-1-piperacinil 5-fluoropirimidina, su preparación y su utilización terapéutica. La presente invención se refiere al compuesto 2-{4-[4-(4,5-dicloro-2-metilimidazol-1-il)butil]-1-piperacinil -5-fluoropirimidina, así como a sus sales fisiológicamente aceptables, de fórmula:
ES009801201A 1997-06-02 1998-05-29 2-4-(4-(4,5-dicloro-2-metilimidazol-1-il)butil)-1-piperacinil)-5-fluoropirimidina, su preparacion y su utilizacion terapeutica. Expired - Fee Related ES2149691B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706738A FR2763950B1 (fr) 1997-06-02 1997-06-02 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique

Publications (2)

Publication Number Publication Date
ES2149691A1 ES2149691A1 (es) 2000-11-01
ES2149691B1 true ES2149691B1 (es) 2001-05-16

Family

ID=9507480

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009801201A Expired - Fee Related ES2149691B1 (es) 1997-06-02 1998-05-29 2-4-(4-(4,5-dicloro-2-metilimidazol-1-il)butil)-1-piperacinil)-5-fluoropirimidina, su preparacion y su utilizacion terapeutica.

Country Status (22)

Country Link
US (2) US6303608B1 (es)
EP (1) EP1007522B1 (es)
JP (1) JP4344890B2 (es)
KR (1) KR100556559B1 (es)
CN (1) CN1094491C (es)
AT (1) ATE228126T1 (es)
AU (1) AU732722B2 (es)
BR (1) BR9810240A (es)
CA (1) CA2292746A1 (es)
DE (1) DE69809564T2 (es)
DK (1) DK1007522T3 (es)
ES (1) ES2149691B1 (es)
FR (1) FR2763950B1 (es)
HU (1) HUP0002905A3 (es)
IL (1) IL133216A0 (es)
NO (1) NO318757B1 (es)
NZ (1) NZ501566A (es)
PL (1) PL190777B1 (es)
PT (1) PT1007522E (es)
RU (1) RU2191184C2 (es)
TR (1) TR199903001T2 (es)
WO (1) WO1998055476A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101152658B1 (ko) * 2009-04-30 2012-06-18 한국과학기술연구원 세로토닌 5-ｈｔ6 길항 활성 효과를 갖는 피페라진 화합물 함유 조성물
RU2660583C1 (ru) * 2017-08-15 2018-07-06 Общество С Ограниченной Ответственностью "Валента - Интеллект" Применение буспирона для лечения функционального головокружения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2712808B1 (fr) * 1993-11-25 1996-02-16 Esteve Labor Dr Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .
FR2742052B1 (fr) * 1995-12-12 1998-04-10 Esteve Labor Dr Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports

Also Published As

Publication number Publication date
US6303608B1 (en) 2001-10-16
PL190777B1 (pl) 2006-01-31
AU732722B2 (en) 2001-04-26
JP2002501539A (ja) 2002-01-15
KR20010013274A (ko) 2001-02-26
JP4344890B2 (ja) 2009-10-14
EP1007522B1 (fr) 2002-11-20
FR2763950A1 (fr) 1998-12-04
CN1094491C (zh) 2002-11-20
KR100556559B1 (ko) 2006-03-06
US6346620B1 (en) 2002-02-12
BR9810240A (pt) 2000-09-05
AU7917098A (en) 1998-12-21
RU2191184C2 (ru) 2002-10-20
CN1261888A (zh) 2000-08-02
EP1007522A1 (fr) 2000-06-14
CA2292746A1 (fr) 1998-12-10
NO995894L (no) 2000-02-01
PL337113A1 (en) 2000-07-31
DE69809564T2 (de) 2003-07-10
ES2149691A1 (es) 2000-11-01
FR2763950B1 (fr) 2002-09-20
WO1998055476A1 (fr) 1998-12-10
TR199903001T2 (xx) 2000-07-21
IL133216A0 (en) 2001-03-19
HUP0002905A2 (hu) 2001-06-28
NO318757B1 (no) 2005-05-02
HUP0002905A3 (en) 2002-01-28
DE69809564D1 (de) 2003-01-02
ATE228126T1 (de) 2002-12-15
PT1007522E (pt) 2003-04-30
NO995894D0 (no) 1999-12-01
NZ501566A (en) 2001-06-29
DK1007522T3 (da) 2003-03-17

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
TR200102360T2 (tr) Tert-butil(E)- (6[2-[4-(4-fluorofenil)-6-izopropil-2-[metil (metilsulfonil)amino]pirimidin-5-il] (4R,6S)-2, 2-dimetil[1,3]dioksan-4-il)asetatın üretim için işlem.
TR200000060T2 (tr) Bir N-fenil-2-pirimidinamin türevinin kristal modifikasyonu ve yapım işlemleri ve kullanımı.
MEP33808A (en) Pharmaceutical compositions comprising a hmg reductase inhibitor
MEP53708A (en) 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition
DE60140581D1 (de) Pharmazeutische Zusammensetzungen beinhaltend Kristallsalze von 7-Ä4-(4-Fluorophenyl)-6-isopropyl-2-Ämethyl(methylsulfonyl)aminoÜpyrimidin-5-ylÜ-(3R,5S)-3,5-dihydroxyhept-6-ensäure
ATE284861T1 (de) N-aralkylaminotetraline als neuropeptid-y-y5- rezeptorliganden
MXPA03001495A (es) Derivados de fenilalanina novedosos.
HK1048474A1 (en) Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones.
EA200401114A3 (ru) Замещённые гидроксиэтиламины
RS53428B (en) COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES
DE60121461D1 (de) Kondensierte pyridoindolderivate
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
RS50229B (sr) Analozi vitamina d3
BR0213990A (pt) Derivados de piperazina tendo atividade antagonìstica de sst1
DE60112960D1 (de) Kondensierte pyridoindolderivate
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
ES2149691B1 (es) 2-4-(4-(4,5-dicloro-2-metilimidazol-1-il)butil)-1-piperacinil)-5-fluoropirimidina, su preparacion y su utilizacion terapeutica.
ATE450498T1 (de) Cycloalken-dicarbonsäure-verbindungen als entzündungshemmende, immunmodulatorische und antiproliferative mittel
NO305082B1 (no) 2-(4-(4-azolbutyl)-1-piperazinyl)-5-hydroksy-pyrimidinderivater, deres fremstilling og anvendelse som legemidler
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
HUP0002791A2 (hu) Szinergetikus fungicid hatóanyag-keverék és alkalmazása
HN2002000354A (es) Sales de acido citrico de un compuesto terapeutico y composiciones farmaceuticas que la contienen
TNSN98119A1 (fr) Nouveaux derives de 4-hydroxy-2h-1-(thio)pyran-2-ones, leurs preparations et leurs utilisations comme rodonticides.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20001101

Kind code of ref document: A1

Effective date: 20001101

FD2A Announcement of lapse in spain

Effective date: 20180807